descriptive
Analysis v1
Scientists can't accurately tell how many slow-growing breast cancers are in the Canadian breast screening data because the information isn't detailed enough—even with the best math tools.
Evidence from Studies
Supporting (1)
0
Community contributions welcome
0
Identification of the Fraction of Indolent Tumors and Associated Overdiagnosis in Breast Cancer Screening Trials
Computational/Algorithm Study
2019 Jan 1Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.